308 related articles for article (PubMed ID: 30667572)
1. The modification of quantity and quality of muscle mass improves the cognitive impairment after TIPS.
Gioia S; Merli M; Nardelli S; Lattanzi B; Pitocchi F; Ridola L; Riggio O
Liver Int; 2019 May; 39(5):871-877. PubMed ID: 30667572
[TBL] [Abstract][Full Text] [Related]
2. The improvement in body composition including subcutaneous and visceral fat reduces ammonia and hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
Gioia S; Ridola L; Cristofaro L; Merli M; Faccioli J; Riggio O; Nardelli S
Liver Int; 2021 Dec; 41(12):2965-2973. PubMed ID: 34543504
[TBL] [Abstract][Full Text] [Related]
3. Sarcopenia Is Risk Factor for Development of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt Placement.
Nardelli S; Lattanzi B; Torrisi S; Greco F; Farcomeni A; Gioia S; Merli M; Riggio O
Clin Gastroenterol Hepatol; 2017 Jun; 15(6):934-936. PubMed ID: 27816756
[TBL] [Abstract][Full Text] [Related]
4. Contributory roles of sarcopenia and myosteatosis in development of overt hepatic encephalopathy and mortality after transjugular intrahepatic portosystemic shunt.
Yin L; Chu SL; Lv WF; Zhou CZ; Liu KC; Zhu YJ; Zhang WY; Wang CX; Zhang YH; Lu D; Cheng DL
World J Gastroenterol; 2023 May; 29(18):2875-2887. PubMed ID: 37274064
[TBL] [Abstract][Full Text] [Related]
5. Predictive value of induced hyperammonaemia and neuropsychiatric profiling in relation to the occurrence of post-TIPS hepatic encephalopathy.
Senzolo M; Zarantonello L; Formentin C; Orlando C; Beltrame R; Vuerich A; Angeli P; Burra P; Montagnese S
Metab Brain Dis; 2019 Dec; 34(6):1803-1812. PubMed ID: 31506797
[TBL] [Abstract][Full Text] [Related]
6. Cognitive Impairment Predicts The Occurrence Of Hepatic Encephalopathy After Transjugular Intrahepatic Portosystemic Shunt.
Nardelli S; Gioia S; Pasquale C; Pentassuglio I; Farcomeni A; Merli M; Salvatori FM; Nikolli L; Torrisi S; Greco F; Nicoletti V; Riggio O
Am J Gastroenterol; 2016 Apr; 111(4):523-8. PubMed ID: 26925879
[TBL] [Abstract][Full Text] [Related]
7. Portosystemic hepatic encephalopathy after transjugular intrahepatic portosystemic shunt in patients with cirrhosis: clinical, laboratory, psychometric, and electroencephalographic investigations.
Nolte W; Wiltfang J; Schindler C; Münke H; Unterberg K; Zumhasch U; Figulla HR; Werner G; Hartmann H; Ramadori G
Hepatology; 1998 Nov; 28(5):1215-25. PubMed ID: 9794904
[TBL] [Abstract][Full Text] [Related]
8. Post-transjugular Intrahepatic Portosystemic Shunt Hepatic Encephalopathy: Sarcopenia Adds Insult to Injury.
Bhatia Kapoor P; Benjamin J; Tripathi H; Patidar Y; Maiwall R; Kumar G; Joshi YK; Sarin SK
Turk J Gastroenterol; 2023 Apr; 34(4):406-412. PubMed ID: 36620928
[TBL] [Abstract][Full Text] [Related]
9. Impact of nutritional status on the outcome of transjugular intrahepatic portosystemic shunt in patients with cirrhosis: a systematic review.
Giri S; Anirvan P; Chaudhary M; Tripathy T; Patel RK; Rath MM; Panigrahi MK
Br J Radiol; 2024 Feb; 97(1154):331-340. PubMed ID: 38276881
[TBL] [Abstract][Full Text] [Related]
10. Improvement of sarcopenia is beneficial for prognosis in cirrhotic patients after TIPS placement.
Liu J; Yang C; Yao J; Bai Y; Li T; Wang Y; Shi Q; Wu X; Ma J; Zhou C; Huang S; Xiong B
Dig Liver Dis; 2023 Jul; 55(7):918-925. PubMed ID: 36682922
[TBL] [Abstract][Full Text] [Related]
11. Sarcopenia in Patients with Cirrhosis after Transjugular Intrahepatic Portosystemic Shunt Placement.
Liu J; Ma J; Yang C; Chen M; Shi Q; Zhou C; Huang S; Chen Y; Wang Y; Li T; Xiong B
Radiology; 2022 Jun; 303(3):711-719. PubMed ID: 35289658
[TBL] [Abstract][Full Text] [Related]
12. Predicting disease progression in cirrhotic patients after transjugular intrahepatic portosystemic shunt implantation: A sex-stratified analysis.
Zhang Q; Long L; Zhu HL; Peng H; Luo XH; Zhu KS; Wang RP
World J Gastroenterol; 2023 Nov; 29(42):5768-5780. PubMed ID: 38075849
[TBL] [Abstract][Full Text] [Related]
13. TIPS placement as the first-line therapy to prevent variceal rebleeding in patients with cirrhosis and sarcopenia.
Xiong B; Yang C; Zhou C; Wu X; Huang S
Eur J Radiol; 2023 Jan; 158():110630. PubMed ID: 36455336
[TBL] [Abstract][Full Text] [Related]
14. Low adipose tissue index as an indicator of hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.
Wang C; Teng Y; Gao J; Zhang Z; Li Y
Abdom Radiol (NY); 2023 Apr; 48(4):1454-1467. PubMed ID: 36735033
[TBL] [Abstract][Full Text] [Related]
15. Controlling nutritional status score as a new indicator of overt hepatic encephalopathy in cirrhotic patients following transjugular intrahepatic portosystemic shunt.
Li J; Feng D; Pang N; Zhao C; Gao L; Liu S; Li L
Clin Nutr; 2022 Feb; 41(2):560-566. PubMed ID: 35032860
[TBL] [Abstract][Full Text] [Related]
16. No effect of albumin infusion on the prevention of hepatic encephalopathy after transjugular intrahepatic portosystemic shunt.
Riggio O; Nardelli S; Pasquale C; Pentassuglio I; Gioia S; Onori E; Frieri C; Salvatori FM; Merli M
Metab Brain Dis; 2016 Dec; 31(6):1275-1281. PubMed ID: 26290375
[TBL] [Abstract][Full Text] [Related]
17. Peripheral and splanchnic indole and oxindole levels in cirrhotic patients: a study on the pathophysiology of hepatic encephalopathy.
Riggio O; Mannaioni G; Ridola L; Angeloni S; Merli M; Carlà V; Salvatori FM; Moroni F
Am J Gastroenterol; 2010 Jun; 105(6):1374-81. PubMed ID: 20125128
[TBL] [Abstract][Full Text] [Related]
18. Risk factors for hepatic encephalopathy and mortality in cirrhosis: The role of cognitive impairment, muscle alterations and shunts.
Nardelli S; Riggio O; Gioia S; Merli M; Spagnoli A; di Martino M; Pelle G; Ridola L
Dig Liver Dis; 2022 Aug; 54(8):1060-1065. PubMed ID: 35058135
[TBL] [Abstract][Full Text] [Related]
19. Pre-transjugular intrahepatic portosystemic shunts (TIPS) prediction of post-TIPS overt hepatic encephalopathy: the critical flicker frequency is more accurate than psychometric tests.
Berlioux P; Robic MA; Poirson H; Métivier S; Otal P; Barret C; Lopez F; Péron JM; Vinel JP; Bureau C
Hepatology; 2014 Feb; 59(2):622-9. PubMed ID: 24620380
[TBL] [Abstract][Full Text] [Related]
20. The effect of hepatic encephalopathy, hepatic failure, and portosystemic shunt on brain volume of cirrhotic patients: a voxel-based morphometry study.
Zhang LJ; Qi R; Zhong J; Xu Q; Zheng G; Lu GM
PLoS One; 2012; 7(8):e42824. PubMed ID: 22912746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
